Prudential Financial’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151K Sell
33,820
-52,910
-61% -$246K ﹤0.01% 2184
2025
Q4
$477K Buy
86,730
+58,385
+206% +$284K ﹤0.01% 1846
2025
Q3
$92.7K Buy
28,345
+5,555
+24% +$15.7K ﹤0.01% 2286
2025
Q2
$52.6K Buy
22,790
+7,650
+51% +$16.6K ﹤0.01% 2342
2025
Q1
$21K Buy
15,140
+2,150
+17% +$3.6K ﹤0.01% 2253
2024
Q4
$22.5K Buy
12,990
+1,800
+16% +$3.73K ﹤0.01% 2270
2024
Q3
$22.5K Hold
11,190
﹤0.01% 2690
2024
Q2
$25.1K Sell
11,190
-7,860
-41% -$22.9K ﹤0.01% 2663
2024
Q1
$54.7K Hold
19,050
﹤0.01% 2582
2023
Q4
$33.7K Buy
19,050
+1,800
+10% +$3.59K ﹤0.01% 2585
2023
Q3
$54.5K Buy
+17,250
New +$32.2K ﹤0.01% 2492

Other funds holding TSHA